• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通急性淋巴细胞白血病抗原(CALLA)阳性骨髓瘤的临床特征:4例报告

Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases.

作者信息

Tamura J, Kurabayashi H, Sawamura M, Murakami H, Nogiwa E, Shinonome S, Miyawaki S, Kubota K, Sato S, Omine M

机构信息

Third Department of Medicine, Gunma University School of Medicine, Japan.

出版信息

Blut. 1989 May;58(5):229-33. doi: 10.1007/BF00320910.

DOI:10.1007/BF00320910
PMID:2524231
Abstract

Four patients with common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma are presented. The subclasses of monoclonal protein were IgD kappa (1 case), IgA lambda (1 case), and IgA kappa (2 cases). Bence Jones proteinuria was seen in all cases. The clinical stages were determined as IIA (2 cases) and IIIA (2 cases). All patients died with a median survival time after diagnosis of 62 days due to rapid development of renal failure (3 cases), and renal insufficiency and pneumonia (1 case). According to light microscopic evaluation, these myelomas corresponded to plasmablastic (1 case), immature (2 cases), and intermediate (1 case) types. Both CALLA and a cytoplasmic immunoglobulin identical with the serum monoclonal protein were simultaneously detected in single cells from all cases using immunofluorescent double labeling. These findings suggest that CALLA-positive and plasma-blastic myelomas constitute clinically a subgroup characterized by extremely poor survival but they represent cytologically different subcategories.

摘要

本文报告了4例普通急性淋巴细胞白血病抗原(CALLA)阳性的骨髓瘤患者。单克隆蛋白的亚类分别为IgD κ(1例)、IgA λ(1例)和IgA κ(2例)。所有病例均出现本周蛋白尿。临床分期确定为IIA期(2例)和IIIA期(2例)。所有患者均因肾衰竭迅速发展(3例)以及肾功能不全和肺炎(1例)在诊断后中位生存时间62天死亡。根据光镜评估,这些骨髓瘤分别对应浆母细胞型(1例)、未成熟型(2例)和中间型(1例)。使用免疫荧光双重标记在所有病例的单个细胞中同时检测到CALLA和与血清单克隆蛋白相同的细胞质免疫球蛋白。这些发现表明,CALLA阳性和浆母细胞性骨髓瘤在临床上构成一个以生存极差为特征的亚组,但它们在细胞学上代表不同的亚类。

相似文献

1
Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases.普通急性淋巴细胞白血病抗原(CALLA)阳性骨髓瘤的临床特征:4例报告
Blut. 1989 May;58(5):229-33. doi: 10.1007/BF00320910.
2
Ultrastructure of myeloma cells in patients with common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma.普通急性淋巴细胞白血病抗原(CALLA)阳性骨髓瘤患者骨髓瘤细胞的超微结构
Cancer Res. 1988 Nov 1;48(21):6234-7.
3
CALLA-positive myeloma: an aggressive subtype with poor survival.CALLA阳性骨髓瘤:一种侵袭性亚型,生存率低。
Blood. 1985 Jul;66(1):229-32.
4
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Blood. 1991 Aug 1;78(3):711-9.
5
Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related.
Hybridoma. 1988 Jun;7(3):227-36. doi: 10.1089/hyb.1988.7.227.
6
Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breast.
Mol Cell Probes. 1989 Mar;3(1):39-44. doi: 10.1016/0890-8508(89)90035-2.
7
Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission.
Hematol Oncol. 1990 Mar-Apr;8(2):91-5. doi: 10.1002/hon.2900080204.
8
A monoclonal antibody to common acute lymphoblastic leukemia antigen (CALLA) and its expression on several human tumor cell lines.一种针对常见急性淋巴细胞白血病抗原(CALLA)的单克隆抗体及其在几种人类肿瘤细胞系上的表达。
J Korean Med Sci. 1992 Jun;7(2):147-53. doi: 10.3346/jkms.1992.7.2.147.
9
Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.白血病和黑色素瘤细胞系上表达的常见急性淋巴细胞白血病抗原具有中性内肽酶活性。
J Clin Invest. 1989 Feb;83(2):713-7. doi: 10.1172/JCI113936.
10
Multiple myeloma: the relationship between CALLA (CD10) positive lymphocytes in the peripheral blood and light chain isotype suppression.
Br J Haematol. 1987 Sep;67(1):39-44. doi: 10.1111/j.1365-2141.1987.tb02293.x.

引用本文的文献

1
Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy.尽管化疗使肿瘤负荷增加,但骨髓瘤蛋白仍无分泌。
Ann Hematol. 1991 Oct;63(4):232-3. doi: 10.1007/BF01703451.

本文引用的文献

1
The bone marrow on sternal aspiration in multiple myeloma.多发性骨髓瘤胸骨穿刺所得的骨髓
Blood. 1948 Sep;3(9):987-1018.
2
Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.多发性骨髓瘤的预处理肿瘤肿块、细胞动力学及预后
Blood. 1980 Mar;55(3):364-72.
3
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.骨髓瘤的骨髓组织学:其在诊断、预后、分类及分期中的重要性。
Br J Haematol. 1982 Jul;51(3):361-75. doi: 10.1111/j.1365-2141.1982.tb02791.x.
4
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues.常见急性淋巴细胞白血病抗原在非造血组织中的分布。
J Exp Med. 1981 Oct 1;154(4):1249-54. doi: 10.1084/jem.154.4.1249.
5
Prognostic relevance of cellular morphology in multiple myeloma.细胞形态学在多发性骨髓瘤中的预后相关性。
Blood. 1984 May;63(5):1072-9.
6
Multiple myeloma: circulating lymphocytes that express plasma cell antigens.多发性骨髓瘤:表达浆细胞抗原的循环淋巴细胞。
Blood. 1984 Aug;64(2):352-6.
7
Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.血清β2微球蛋白与多发性骨髓瘤的生存时间:一种简单可靠的分期标志物。
Br J Haematol. 1983 Nov;55(3):439-47. doi: 10.1111/j.1365-2141.1983.tb02158.x.
8
Multiple myeloma: significance of plasmablastic subtype in morphological classification.多发性骨髓瘤:浆母细胞亚型在形态学分类中的意义
Blood. 1985 Feb;65(2):305-10.
9
CALLA-positive myeloma: an aggressive subtype with poor survival.CALLA阳性骨髓瘤:一种侵袭性亚型,生存率低。
Blood. 1985 Jul;66(1):229-32.
10
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.多发性骨髓瘤患者骨髓中恶性浆细胞前体的鉴定
J Clin Invest. 1985 Sep;76(3):1243-51. doi: 10.1172/JCI112080.